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doi:10.1016/j.ejvs.2010.01.006Abstract Objectives: To compare the outcome of the one-stage basilic vein transposition
(BVT) fistula with a modified, two-stage technique.
Design: Retrospective case-controlled study, performed in an academic centre.
Material: A total of 173 candidates for BVT fistula (87 males, mean age 61 years).
Methods: In one-stage BVT, the basilic vein is mobilised through a single incision, placed inside
an anterolateral arm tunnel and anastomosed with the brachial artery. In two-stage proce-
dures, the fistulaearterial anastomosis is created first, followed by the second stage, after
fistula maturation several weeks later, when the basilic vein is mobilised through two skip inci-
sions, transected near the anastomosis, placed inside an anterolateral arm tunnel and reanas-
tomosed. Morbidity and fistula maturation rate were the main outcome measures.
Results: In one-stage BVT (nZ 76), the incidence of venous hypertension, wound haematomas
and all complications (17%, 13% and 43%, respectively) was significantly higher than in two-
stage procedures (nZ 98) (4%, pZ 0.004, 3%, pZ 0.012 and 11%, p< 0.001, respectively).
Time (68 days) to fistula use was significantly decreased in one-stage BVT than in two-stage
procedures (132 days, p< 0.001) but failure to mature rate was equivalent (15% vs. 18%,
pZ 0.49).
Conclusions: Our results indicate that the two-stage BVT fistula through two skip-arm incisions
is superior to the established one-stage procedure in terms of less morbidity but at the cost of
a second operation and longer time to access use. Further research comparing these two tech-
niques is necessary. Until this issue is resolved, an individualised approach is suggested.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
The Kidney Disease Outcome Quality Initiative (KDOQI)
guidelines have recommended that, in patients with3 9167308.
g (G.K. Haddad).
ty for Vascular Surgery. Publishechronic kidney disease, autogenous radiocephalic or,
alternatively, brachiocephalic fistula should be the
preferred types of vascular access.1,2 In case the cephalic
vein or the radial artery is not suitable for creating and by Elsevier Ltd. All rights reserved.
Staged-basilic Vein Transposition 613autogenous fistula or if such accesses fail, the use of the
basilic vein transposition (BVT) fistula has been suggested,
followed by prosthetic grafts. Although Cascardo described
first the brachio-basilic fistula in 1970,3 Dagher performed
the first BVT in 1976, as a one-stage procedure4; during the
subsequent years, BVT fistula underwent several technical
modifications.5e12 Preferential use of BVT fistulas over
prosthetic grafts was suggested for the first time in the 2006
update of the KDOQI guidelines.1 To comply with the
guidelines, our practice has seen a dramatic increase in the
number of BVT fistulas being performed.
Staging of BVT was suggested sometime ago13; however,
the only supporting evidence comes from a single and small
study, which found improved patency rates with procedure
staging compared with the well-known one-stage tech-
nique.5 The obvious disadvantage of procedure staging is
the extra delay in BVT use. Herein, we present a modified
two-stage technique for BVT (the transposition being per-
formed through two skip-arm incisions), and compare this
new method with the established one-stage procedure in
terms of morbidity and maturation rate.Patients and methods
A total of 173 consecutive patients referred to the Vascular
Access Outpatient Clinic during a 5-year period and candi-
dates deemed suitable for BVT fistula were included.
Patients were eligible if they had a suitable basilic vein size
(2.5 mm) on ultrasound or venogram, and brachial artery
size (3 mm) confirmed by intra-operative findings.
A flowchart of all BVT fistulas is shown in Fig. 1. Patients
were scheduled to have BVT, as a one-stage (nZ 76) or
a two-stage procedure (nZ 98) (one patient had two
procedures performed), based on the individual surgeon’s
preference. In four patients the inflow artery was the radial
artery and in one the ulnar artery (instead of the brachial
artery), while in three patients the outflow during the first
of the two-stage procedures was the median antecubital
vein that drained preferentially to the basilic vein, and this
was established during the second stage. Twenty patients
were in prehaemodialysis. Transposition was not performed
in 16 patients as planned because the fistula thrombosed
before the second stage (nZ 4) or failed to mature and was
abandoned during the re-exploration (nZ 12); six of the
patients in the latter group had a prosthetic graft placed
and one more patient had a brachiocephalic fistula per-
formed. In 10 patients, the second-stage procedure was not
performed, because either the patient refused (nZ 3, one
of them switched to peritoneal dialysis), or was lost to
follow-up (nZ 1), or died (nZ 2), or developed venous
hypertension (nZ 2) or ischaemic monomelic neuropathy
(nZ 1, requiring fistula ligation) or moved out of the state
(nZ 1). Finally, 148 patients underwent BVT, as a one-
stage (nZ 76) or a two-stage procedure (nZ 72). The
study was approved by the hospital institutional review
board.
Baseline demographics are shown in Table 1. More
females had two-stage procedures. General anaesthesia
(as opposed to regional with local anaesthesia and seda-
tion) was also used more often in one-stage BVT fistula
(21%) than in the two-stage procedures (4%, p< 0.001).BVT fistula was a primary access in 33% of one-stage
procedures compared with 69% in two-stage procedures
(p< 0.001).
Surgical techniques
In one-stage procedures, the basilic vein is usually mobi-
lised through a single-arm incision along the course of the
basilic vein (Fig. 2); if necessary, the incision is extended
transversely to the antecubital fossa. The medial ante-
brachial cutaneous nerve (Fig. 2) is carefully protected.
The basilic vein is disconnected and dilated with hepari-
nised solution (Fig. 3) and then transposed inside an ante-
rolateral subcutaneous tunnel; following patient
heparinisation (3000 units of unfractionated heparin,
intravenously), the basilic vein is anastomosed to the
brachial artery (Fig. 4) or proximal radial or ulnar artery
with 7/0 polypropylene suture. In two-stage procedures,
the basilic vein is mobilised through a transverse ante-
cubital fossa incision followed by creation of the fistula.
Following a period of 4e6 weeks necessary for maturation,
the second stage involves mobilisation of the basilic vein
through two longitudinal skip incisions (Fig. 5), one over the
distal part of the basilic vein near its anastomosis and one
at the level of the proximal arm to allow full mobilisation of
the basilic vein up to its confluence with the brachial vein;
the basilic vein is mobilised by dividing all tributaries with
4/0 silk suture and/or surgical clips for the distal vein
stumps. Subsequently, a superficial anterolateral arm
tunnel is made between the two incisions with a tunneller
(Fig. 6), with care taken not to make the tunnel too deep;
the patient is given 3000 units of unfractionated heparin,
intravenously; the anterior surface of the arterialised
fistula is marked using a marker pen and the proximal part
of the fistula near the anastomosis is controlled with
a bulldog clamp followed by fistula transection; the vein is
retracted off the proximal incision, dilated with the hep-
arinised solution (Fig. 6) and placed inside the tunnel, with
care taken not to twist the fistula, using the top marks.
Then, the two ends of the fistula are re-anastomosed with
7/0 polypropylene suture (Fig. 7). The anastomosis is tested
for leaks followed by haemostasis and wound closure
(Fig. 8). Wound suction or heparin reversal is not used
routinely; all procedures are performed as outpatient
procedures; in case of complications, the patient is
observed in the short-stay unit.
BVT fistula maturation
Patients were followed in the outpatient clinic for post-
operative care including detection and management of
complications and assessment of fistula maturation, the
latter being based on the physical examination (develop-
ment of basilic vein dilatation and thrill for a sufficient
length).1 Following one-stage procedures, fistulas were
released for dialysis after at least 6 weeks to allow the
fistula to mature. Following two-stage procedures, fistulas
were assessed for maturation and patients were scheduled
for the transposition procedure after 4e6 weeks; fistulas
were released for dialysis after at least 3 weeks following
the second procedure.
Figure 1 Flow chart of the patients who participated in the study and final outcome.
614 S.K. Kakkos et al.Endovascular treatment and surgical revision to
assist maturation
BVT fistulas that failed to mature were investigated with angi-
ography. Depending on the angiogram findings, angioplasty
(stenting) of the anatomical lesion (arterial anastomosis,
fistula body, venous outflow, draining or central veins) respon-
sible for poor maturation or surgical revision was performed.
Statistics
SPSS 14.0 for Windows (SPSS Inc., Chicago, IL, USA) was
used for statistical analysis. Reporting standards forTable 1 Demographics of the patients of the two study groups
BVT fistula
One-stage (nZ 76
Age (mean sd, years) 59 15
Gender (male/female) 46/30
Race (black/other) 61/15
Diabetes (%) 45 (59%)
History of previous access (%) 51 (67%)
Prehemodialysis (%) 6 (8%)
Access side (L/R) 60/16
General anesthesia (%) 16 (21%)
a Two patients had also regional with local anesthesia and sedationarterio-venous accesses were used to define complica-
tions,14 with grades 1 and 2 referring to complications that
subsided with conservative management and grade 3 to
complications necessitating re-intervention or leading to
access loss. The KolmogoroveSmirnov test was used to test
numerical data for normal distribution; normally distrib-
uted data were expressed as mean SD and compared with
the t-test; otherwise they were expressed as median and
interquartile range (IQR) and the ManneWhitney test was
used. Categorical data were analysed with the chi-square
(or the Fisher’s exact test where appropriate), while odds
ratios (ORs) (with 95% confidence interval (CI)) were
calculated to compare the risk between groups. Binary, one and two-stage basilic vein transposition (BVT) fistula.
p Value
) Two-stage (nZ 98)
62 16 0.14
41/57 0.01
73/25 0.37
57 (58%) 0.89
30 (31%) <0.001
14 (14%) 0.19
71/27 0.32
4 (4%)a <0.001
during the first and second stage, respectively.
Figure 2 This figure shows a basilic vein mobilized through
a single incision along the medial aspect of the arm in prepa-
ration for a one-stage transposition procedure. The vein is
dissected (arrow) in its entire length by dividing all tributaries
with 4/0 silk suture. The medial antebrachial cutaneous nerve
and its branches (arrowhead) are carefully protected.
Figure 4 The basilic vein, shown, is transposed inside an
anterolateral subcutaneous arm tunnel and anastomosed to
the brachial artery (arrow). The preserved medial antebrachial
cutaneous nerve is also noted (arrowhead).
Staged-basilic Vein Transposition 615logistic regression was used to test the influence of clinical
parameters on wound haematoma and fistula maturation
rates. A p value <0.05 was considered as statistically
significant.
Results
Morbidity and mortality
Procedure complications are shown in Table 2. In one-stage
BVT fistula, the incidence of venous hypertension, wound
haematomas and all complications (17%, 13% and 43%,
respectively) was significantly higher than in the two-stage
BVT fistula procedures in both an intention to treat (4%,
pZ 0.004, 3%, pZ 0.012 and 11.2%, p< 0.001, respec-
tively) and a per protocol (4%, pZ 0.004, 4.2%, pZ 0.053
and 11.1%, p< 0.001, respectively) analysis. Most woundFigure 3 The dissected basilic vein, shown in Fig. 2, is
disconnected and dilated with heparinized solution to assess its
size, quality and identify points of fluid leakage that need to be
repaired with 7/0 polypropylene suture before the vein is
placed inside the tunnel and flow is restored. The brachial
artery, controlled with vessel loops, is also shown (arrow); it
was approximately 3 mm in size.haematomas were successfully managed conservatively
(grade 1 or 2), but three of them required re-exploration
(grade 3). All patients but one with venous hypertension
were successfully managed conservatively (grade 1 or 2).
There was no association between the clinical character-
istics shown in Table 1 and the development of an individual
or any complication, with the exception of wound compli-
cations, which developed more often in patients operated
on under general anaesthesia (OR 38, p< 0.001 e intention
to treat analysis). An interaction between wound haema-
toma and venous hypertension was also noted. The inci-
dence of wound haematoma in patients who developed
venous hypertension (18%) was higher than in those patients
who did not manifest venous hypertension (6%, pZ 0.12,
OR 3.1, 95% CI 0.78e12.8 e intention to treat analysis). On
multivariate analysis, however, only procedure type (one-Figure 5 This figure demonstrates the second stage of a two-
stage procedure with mobilization of the basilic vein through
two longitudinal small skip incisions along the course of the
basilic vein, one over the distal part of the basilic vein near its
anastomosis and one at the level of the proximal arm to allow
full mobilization of the basilic vein up to its confluence with
the brachial vein; the basilic vein is mobilized in its entire
length by dividing all tributaries with 4/0 silk suture and/or
surgical clips for the distal veins stumps, especially if they are
inaccessible. The marked scar of the incision made during the
first stage of the procedure is also shown (arrow).
Figure 6 The basilic vein shown is retracted off the proximal
incision and dilated with heparinized solution to assess its size,
quality and identify points of fluid leakage.
Figure 8 Wound closure is performed with a continuous
4/0 absorbable suture for the subcutaneum and stainless steel
staples for the skin; again the course of the tunnel is visible
(arrow).
616 S.K. Kakkos et al.stage BVT) predicted postoperative wound haematoma
(pZ 0.021, OR 4.8, 95% CI 1.2e18.1).
There was no difference in the incidence of steal
syndrome between the two methods. Although there was
no association of steal syndrome with any clinical param-
eter, a trend was noted towards steal being more common
in patients with previous vascular access (4.9%) than in
those who did not have such access (1.1%, pZ 0.19). All
patients with steal syndrome were successfully managed
conservatively.
The thirty-day mortality of one- and two-stage proce-
dures was 1.3% (1/76) and 0%, respectively (pZ 0.44,
Fisher’s exact test).
Fistula maturation rate and ancillary procedures
In 29 patients (11 patients with one-stage procedures and
18 patients with two-stage procedures), the fistula failed to
mature (Fig. 1). There was no difference between the two
groups on both intention to treat (14.5% and 18.4%,
respectively, pZ 0.49) and per protocol (14.5% and 8.3%,
respectively, pZ 0.24) analysis. Multivariate analysis (onFigure 7 The basilic vein shown is placed inside an antero-
lateral subcutaneous arm tunnel and reanastomosis of the two
end of the fistula is performed (arrow). Since the fistula was
already matured, the course of the tunnel can be seen easily
(arrowhead).a per protocol approach) identified venous hypertension,
not procedure staging, clinical characteristics or other
complications (wound haematoma or other problems), as
the single predictor of poor maturation (pZ 0.010, OR 5,
95% CI 1.5e17). Angioplasty was performed in nine fistulas
that failed to mature; this was successful in assisting the
fistula to mature in seven cases. Surgical revision was per-
formed in four patients (including a patient who had an
angioplasty performed). Revision procedures included
patch plasty of the venous outflow, placement of an
interposition graft, placement of a jump graft and redo-
transposition (Fig. 1).
Time to fistula use
Excluding patients in prehaemodialysis, median IQR time to
haemodialysis for one- and two-stage procedures was 68
(49e103 days) and 132 (102e166 days) days, respectively
(p< 0.001). In two-stage procedures, the interval between
stages and between the second surgery and haemodialysis
was 77 (56e105) days and 43.5 (29.5e72) days, respec-
tively. In 30 patients who had a two-stage procedure, there
was an excessive delay (>12 weeks) between stages
because of interval patient illness or willingness. This was
the reason for the longer time it took for the two-stage BVT
fistulas to be used than the one-stage procedures. Median
time to BVT use after the transposition procedure in
patients, who developed complications, was 66 days
compared to 50 days in those who did not develop such
complications (pZ 0.019).
Discussion
In the present study, we describe a modification of the two-
stage procedure for creating BVT fistula and demonstrated
significantly lower morbidity than in the conventional one-
stage procedure, performed through a single incision, but
at the cost of a longer time to fistula use. The use of the
basilic vein is crucial in patients who have exhausted other
autologous options,15 and can support an ‘all autogenous
policy’ reducing the use of prosthetic grafts.16e18
Table 2 Distribution of postoperative complications of basilic vein transposition (BVT) fistulae in relation to surgical technique
(one or two-stage procedures) on both, intention to treat and per protocol analysis. Some patients had more than one
complication.
Complication One-stage BVT
fistula (nZ 76)
Intention to treat analysis Per protocol analysis
Two-stage BVT
fistula (nZ 98)
p Odds ratio
(95% CI)
Two-stage BVT
fistula (nZ 72)
p Odds ratio
(95% CI)
Wound hematoma 10 (13%)a 3 (3.1%)b 0.012 4.80 (1.27e18.1) 3 (4.2%)b 0.053 3.48 (0.92e13.22)
Wound dehiscence
or infection
5 (6.6%) 0 (0%) 0.015 N/A 0 (0%) 0.059 N/A
Steal syndrome 3 (3.9%) 2 (2%) 0.65 1.97 (0.32e12.1) 2 (2.8%) 0.65 1.00 (0.23e1.44)
Venous hypertension 13 (17%) 4 (4%) 0.004 4.85 (1.51e15.55) 2 (2.8%) 0.004 7.22 (1.57e33.26)
Other 8 (10.5%) 3 (3.1%) 0.06 3.72 (0.95e14.56) 2 (2.8%) 0.10 4.12 (0.84e20.1)
All complications 33 (43.4%) 11 (11.2%) <0.001 6.07 (2.80e13.16) 8 (11.1%) <0.001 6.14 (2.59e14.56)
Failure to mature 11 (14.5%) 18 (18.4%) 0.49 0.75 (0.33e1.70) 6 (8.3%) 0.24 1.86 (0.65e5.33)
CI: confidence interval.
a Wound exploration in two patients.
b Wound exploration in one patient.
Staged-basilic Vein Transposition 617To improve the results of BVT, several technical modi-
fications have been proposed, including procedure
staging,5,7 endoscopic basilic vein dissection,6 partial
basilic vein mobilisation,8,11 superficialisation instead of
formal transposition,9 basilic vein dissection through skip
incisions and transposition in one-stage procedure10 and
basilic vein transection near its confluence with the
brachial vein.12 Our procedure is similar to the technique
described by Hill, who also used two skip incisions,10 but in
one stage instead of two. In the absence of previous
arterialisation, the basilic vein can be very thin-walled and
friable, susceptible to damage in one-stage procedures.
Although technical modifications, such as the one that used
a hydrophilic wire inserted inside the basilic vein, may
allow one-stage procedures to be done with minimal vein
damage, we believe that the two-stage technique with
interval arterialisation and thickening of the basilic vein
wall is superior.5,7 Further, the basilic vein may be twisted
or compressed by haematoma in the tunnel more often in
one-stage procedures than in two-stage procedures.19 An
additional benefit of the two-stage technique is that, in
case steal syndrome or venous hypertension develops after
the first stage, these can be managed before the trans-
position is performed.8 This was the case in both patients
who developed steal syndrome and had the two-stage
procedure performed after this problem was resolved.
Alternatively, the transposition procedure can be post-
poned forever should non-correctable complications
develop after the first stage, as in two of our patients who
developed venous hypertension (Fig. 1).
Although the complexity of the two-stage technique
makes it less attractive, the additional delay in fistula use
and therefore continuous patient risk due to catheter use
should be considered as the major drawback of this
method.20 In the original description of the two-stage
technique, the transposition procedure was performed
after 2e3 weeks, but others recommend a 5e8 week
interval between stages, to allow the basilic vein to fully
mature.7,12 This time interval was 73 days in one study,19
similar to what we reported; obviously, the additionaltime after the transposition procedure causes further
delays in starting using the fistula, which compares unfav-
ourably with one-stage BVT fistulas and non-transposed
autogenous fistulas, known to mature on average after 70
days and 2.5e4 months, respectively.20e22 Unfortunately,
a significant proportion of our patients could not have the
second (transposition) procedure performed when this was
scheduled. To avoid the delay inherent with the two-stage
technique, its selective use for basilic veins smaller that
4 mm, which are more likely to fail to mature, has been
suggested.10,23
Early and late haemodialysis-related, morbidity of BVT
fistula has been reported to be as high as 44e55%.9,24
Postoperative wound haematomas have been reported to
occur in 3.6e11%,9,19,21,25e29 necessitating wound explora-
tion in 2.5e6.5% cases.21,25,27,29e31 A low rate of haema-
tomas, 3%, was noted after two-stage procedures in our
series, significantly lower than the corresponding 13% rate
in one-stage procedures, despite the fact that the same
amount of IV heparin was given to both groups; the exact
reason for this difference is not known, although the bigger
incision in one-stage procedures should be responsible.
Several technical modifications of BVT6,8e11 have a common
denominator, which is the minimal tissue dissection in an
effort to reduce trauma and stress, highly desirable in this
frail patient population. Despite ‘minimal dissection’ in
two-stage procedures, re-exploration rates were similar in
the two groups, but not wound dehiscence or infection,
which were observed exclusively in one-stage procedures,
occurring in 7% of them. The latter findings again are likely
the result of a single long incision and favour the two-stage
technique. Venous hypertension has been reported to occur
between 3.6e25%.9,27,32 Different reporting criteria might
explain the wide variability of its incidence reported in the
literature. Although severe symptoms are rare,19 mild
transient arm edema is frequent and usually under-
reported.19 Venous hypertension, as defined by the
reporting standards,14 occurred more often after one-stage
procedures in our study (17% vs. 4% in two-stage proce-
dures) and also in patients who developed wound
618 S.K. Kakkos et al.haematomas; multivariate analysis, however, identified
only procedure staging, not venous hypertension, as an
independent predictor of wound haematomas. We believe
that the association between wound haematoma and
venous hypertension is due to the fact that venous hyper-
tension can aggravate bleeding and vice versa; haemato-
mas can compress outflow veins aggravating venous
hypertension. There was no difference between the two
groups in terms of steal syndrome, which is known to
complicate the BVT fistulas in 3.2e6.5% cases.25,26,28,29,31
Steal syndrome necessitating fistula ligation has been
reported in up to 6.5% of all cases.26
The rates of failure to mature were equivalent for the
two study groups. BVT fistulas fail to mature in 3e38%
cases,20,21,25,27,30,32 with most reports being well above the
recommended 70% ‘working’ fistula access rate.1 This wide
range is probably the result of different selection criteria,
mainly vein size on preoperative ultrasound,22 or variability
in the definition of fistula maturation.1,33,34 The latter can
be based on either physical examination,1,35 ultrasound32 or
fistula functionality.36 The only randomised study that
compares the one- with the two-stage techniques was
underpowered with respect to maturation rate.5 Based on
the results of this study, which showed that a significant
percentage of basilic veins did not mature after the first
stage of two-stage procedures, and taking into account that
it is often difficult to feel a deeply located basilic vein
despite adequate arterialisation, objective measurement
of maturation, using ultrasound to estimate the basilic vein
diameter and perform flow measurements, could be of
utmost importance before proceeding to the second stage,
which could be postponed or abandoned in case of poor
maturation. This hypothesis deserves further study. Time to
maturation observed in this study was consistent with
previous reports of 2.5e5.5 months.20,21,32 Consistent with
previous series, a small percentage of our patients required
assisted maturation with angioplasty or surgical
revision.22,25,30,37
The main limitations of our study include its non-
randomised design and the lack of long-term results. A
randomised trial, stratified by basilic vein size, would be
required to answer the question as to which is the best
technique. Probably, basilic veins larger than 4 mm (espe-
cially in the setting of a previous ipsilateral access) could
be safely transposed as a one-stage procedure, while those
that are smaller than 4 mm could be managed with a staged
procedure, as previously suggested.10,23
In conclusion, our results indicate that two-stage BVT
fistula performed through two skip arm incisions has less
complications than the established one-stage procedure,
but at the cost of a second operation and longer time to
access use. A randomised controlled trial to compare the
short-term outcome and patency rates of these two
methods is necessary. Until this evidence becomes avail-
able, an individualised approach is suggested.
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